Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 1 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Neoplasms 85Carcinoma, Non-Small-Cell Lung 75Breast Neoplasms 73Recurrence 64Colorectal Neoplasms 62Pancreatic Neoplasms 59Multiple Myeloma 57Melanoma 56Carcinoma, Hepatocellular 56Advanced Solid Tumor 55Leukemia, Myeloid, Acute 53Advanced Solid Tumors 53Lymphoma 52Neoplasm Metastasis 50Stomach Neoplasms 45Precursor Cell Lymphoblastic Leukemia-Lymphoma 44Solid Tumor 39Lymphoma, B-Cell 39Ovarian Neoplasms 38Lymphoma, Non-Hodgkin 37Lung Neoplasms 35Glioblastoma 35Prostatic Neoplasms 34Leukemia 28Head and Neck Neoplasms 27Leukemia, Lymphocytic, Chronic, B-Cell 26Uterine Cervical Neoplasms 25Burkitt Lymphoma 24Esophageal Neoplasms 22Urinary Bladder Neoplasms 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Unknown × Disease Attributes × Clear all
NCT03114670 2017-06-14

Donor-derived Anti-CD123-CART Cells for Recurred AML After Allo-HSCT

Affiliated Hospital to Academy of Military Medical Sciences

Phase 1 Unknown
20 enrolled
Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Neoplasms by Histologic Type, Recurrence, Leukemia, Myeloid, Acute, Disease Attributes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡